Published in Am J Obstet Gynecol on September 01, 2003
Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants. Blood (2015) 1.42
CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood (2006) 1.14
Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp Hematol (2008) 0.86
Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study. PLoS One (2013) 0.79
Long-term follow-up study on the engraftment of human hematopoietic stem cells in sheep. Exp Anim (2014) 0.75
Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol (2006) 3.00
The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med (2008) 2.70
Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. Hum Immunol (2006) 2.54
Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med (2007) 2.49
Intact fetal cells in maternal plasma: are they really there? Lancet (2003) 2.09
Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin Chem (2004) 1.79
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
In utero haematopoietic stem cell transplantation. Experiences in mice, sheep and humans. Swiss Med Wkly (2006) 1.49
Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood. Transfusion (2008) 1.45
Potential markers of preeclampsia--a review. Reprod Biol Endocrinol (2009) 1.44
Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia. Semin Immunopathol (2007) 1.37
Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem (2005) 1.27
Novel real-time quantitative PCR test for trisomy 21. Clin Chem (2002) 1.26
Digital PCR: a powerful new tool for noninvasive prenatal diagnosis? Prenat Diagn (2008) 1.24
Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem (2004) 1.23
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Mol Cancer (2009) 1.20
Neutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia? Semin Immunopathol (2007) 1.15
Decreased mitochondrial DNA content in blood samples of patients with stage I breast cancer. BMC Cancer (2009) 1.14
First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol (2008) 1.12
Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA (2005) 1.10
Sirenomelia, the mermaid syndrome--detection in the first trimester. Prenat Diagn (2003) 1.08
Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes. Am J Obstet Gynecol (2010) 1.07
Tumor size and detection in breast cancer: Self-examination and clinical breast examination are at their limit. Cancer Detect Prev (2008) 1.06
Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility. J Androl (2008) 1.05
High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res (2008) 1.05
Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet (2007) 1.05
Serum markers for predicting pre-eclampsia. Mol Aspects Med (2007) 1.03
Increased concentrations of antibody-bound circulatory cell-free DNA in rheumatoid arthritis. Clin Chem (2007) 1.03
Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J Cancer Res Clin Oncol (2009) 1.03
Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch Gynecol Obstet (2010) 1.02
Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res (2008) 1.01
Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer. Mod Pathol (2010) 1.01
The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy (2002) 1.00
Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors. Obstet Gynecol (2008) 0.99
The multipotency of luteinizing granulosa cells collected from mature ovarian follicles. Stem Cells (2009) 0.98
Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn (2007) 0.98
Detection of fetal DNA and RNA in placenta-derived syncytiotrophoblast microparticles generated in vitro. Clin Chem (2004) 0.98
Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin Chem (2005) 0.97
Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part I--Folate, Vitamin B12, Vitamin B6. J Matern Fetal Neonatal Med (2010) 0.95
Occurrence of neutrophil extracellular DNA traps (NETs) in pre-eclampsia: a link with elevated levels of cell-free DNA? Ann N Y Acad Sci (2006) 0.94
Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features. J Surg Oncol (2007) 0.92
Nucleic acid based biosensors: the desires of the user. Bioelectrochemistry (2005) 0.92
New trends in molecular biomarker discovery for breast cancer. Genet Test Mol Biomarkers (2009) 0.92
Shall we put the world on folate? Lancet (2009) 0.92
Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficiency or excess. Part II--vitamin D, vitamin A, iron, zinc, iodine, essential fatty acids. J Matern Fetal Neonatal Med (2010) 0.91
Impact of fetal-maternal microchimerism on women's health--a review. J Matern Fetal Neonatal Med (2007) 0.91
A case of maternal herpes simplex virus encephalitis during late pregnancy. Nat Clin Pract Neurol (2009) 0.91
T4 breast cancer under closer inspection: a case for revision of the TNM classification. Breast (2007) 0.91
MALDI-TOF mass array analysis of RASSF1A and SERPINB5 methylation patterns in human placenta and plasma. Biol Reprod (2010) 0.91
Umbilical cord blood stem cells: what to expect. Ann N Y Acad Sci (2010) 0.91
A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry. Clin Chem Lab Med (2008) 0.91
Attitudes of Swiss mothers toward unrelated umbilical cord blood banking 6 months after donation. Transfusion (2003) 0.90
Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: a case-controlled multicenter study. Arch Gynecol Obstet (2006) 0.90
Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci (2008) 0.90
A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol (2006) 0.90
FISH analysis of all fetal nucleated cells in maternal whole blood: improved specificity by the use of two Y-chromosome probes. J Histochem Cytochem (2005) 0.90
Simultaneous quantitative assessment of circulating cell-free mitochondrial and nuclear DNA by multiplex real-time PCR. Genet Mol Biol (2009) 0.90
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for genotyping of human platelet-specific antigens. Transfusion (2008) 0.89
Developments in laboratory techniques for prenatal diagnosis. Curr Opin Obstet Gynecol (2002) 0.89
Lung cancer during pregnancy involving the products of conception and a review of the literature. Arch Gynecol Obstet (2002) 0.89
Simultaneous isolation of DNA, RNA, and proteins for genetic, epigenetic, transcriptomic, and proteomic analysis. J Proteome Res (2009) 0.89
Circulating cell-free DNA as a potential biomarker for minimal and mild endometriosis. Reprod Biomed Online (2009) 0.89
Syncytiotrophoblast micro-particles do not induce apoptosis in peripheral T lymphocytes, but differ in their activity depending on the mode of preparation. J Reprod Immunol (2005) 0.88
Decrease in lipid levels of syncytiotrophoblast micro-particles reduced their potential to inhibit endothelial cell proliferation. Arch Gynecol Obstet (2007) 0.87
Molecular methods for rapid detection of aneuploidy. J Appl Genet (2005) 0.87
Current understanding of mitochondrial DNA in breast cancer. Breast J (2009) 0.87
Maternal laboratory stress influences fetal neurobehavior: cortisol does not provide all answers. J Matern Fetal Neonatal Med (2010) 0.86
Examination of maternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies. Fetal Diagn Ther (2006) 0.86
Maternal and neonatal infections and obstetrical outcome in water birth. Eur J Obstet Gynecol Reprod Biol (2006) 0.86
Recent progress in non-invasive prenatal diagnosis. Semin Fetal Neonatal Med (2008) 0.86
Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early- and late-onset preeclampsia. Clin Chem (2005) 0.85
Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin Immunopathol (2006) 0.85
The impact of intrapartum factors on umbilical cord blood stem cell banking. J Perinat Med (2003) 0.85
Stem cells from umbilical cord Wharton's jelly from preterm birth have neuroglial differentiation potential. Reprod Sci (2013) 0.84
MALDI-TOF MS in Prenatal Genomics. Transfus Med Hemother (2009) 0.84
Previous birth experience and birth anxiety: predictors of caesarean section on demand? J Psychosom Obstet Gynaecol (2009) 0.83
Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited beta-thalassemia point mutation by MALDI-TOF mass spectrometry. Fetal Diagn Ther (2009) 0.83
Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method. Ann N Y Acad Sci (2006) 0.83
Is the quantity of circulatory cell-free DNA in human plasma and serum samples associated with gender, age and frequency of blood donations? Ann Hematol (2006) 0.83
Neurogenic characteristics of placental stem cells in preeclampsia. Am J Obstet Gynecol (2010) 0.83
Analysis of plasma elastase levels in early and late onset preeclampsia. Arch Gynecol Obstet (2005) 0.83
Proteomics and biomarkers for ovarian cancer diagnosis. Ann Clin Lab Sci (2010) 0.83
Influence of volume preloading on uteroplacental and fetal circulation during spinal anaesthesia for caesarean section in uncomplicated singleton pregnancies. Fetal Diagn Ther (2002) 0.83
In utero transplantation of autologous and allogeneic fetal liver stem cells in ovine fetuses. Am J Obstet Gynecol (2004) 0.83
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples. Breast Cancer Res (2006) 0.83
Cell-free foetal DNA in maternal plasma does not appear to be derived from the rich pool of cell-free foetal DNA in amniotic fluid. Arch Gynecol Obstet (2005) 0.82
Engraftment kinetics of human cord blood and murine fetal liver stem cells following in utero transplantation into immunodeficient mice. Stem Cells Dev (2004) 0.82
Cell-free fetal DNA in the maternal circulation does not stem from the transplacental passage of fetal erythroblasts. Mol Hum Reprod (2002) 0.82
Isolation of serum nucleic acids for fetal DNA analysis: comparison of manual and automated extraction methods. Prenat Diagn (2008) 0.82
Use of an automated method improves the yield and quality of cell-free fetal DNA extracted from maternal plasma. Clin Chem (2005) 0.81